Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
257 0 |
Căutarea după subiecte similare conform CZU |
616.98:579.861.2-036.1-07 (1) |
Boli transmisibile. Boli infecţionase şi contagioase, stări febrile (586) |
Microorganisme. Bacterii (186) |
SM ISO690:2012 BUGA, Diana, PRISAKARI, Viorel I.. Risk factors and socio-economic impact in infections with meticyllin-resistant Staphylococcus. In: Revista de Ştiinţe ale Sănătăţii din Moldova, 2022, nr. 3 An.1(29), p. 121. ISSN 2345-1467. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Revista de Ştiinţe ale Sănătăţii din Moldova | ||||||
Numărul 3 An.1(29) / 2022 / ISSN 2345-1467 | ||||||
|
||||||
CZU: 616.98:579.861.2-036.1-07 | ||||||
Pag. 121-121 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Background. Purulent-septic infections (PSIs) with methicillinresistant Staphylococcus (MRS) are a serious challenge for medical institutions; MRS is associated with poorer clinical outcomes and higher healthcare costs compared to infections caused by methicillin-sensitive Staphylococcus (MSS). Objective of the study. To determine risk factors and socioeconomic impact in purulent-septic infections with MRS. Material and Methods. The determination of risk factors and socio-economic impact in infections caused by MRS strains was performed based on a retrospective case-control study. The research group included 269 medical records of patients with PSIs with MRS, the control group 193 medical records of patients with PSIs with MSS. Results. Microbial associations, treatment in intensive care units, repeated hospitalizations, the presence of surgery and people over 50 years of age have been shown to be risk factors for MRS infections. The socio-economic impact of patients with PSIs with MRS is much higher compared to patients with MSS, according to the main criteria (number of hospital bed days, expenses per patient, lethality rate), the situation is much more serious in patients with MRS, differences between hospital bed days (19.5 days vs. 12.8 days) and expenses (11 272 lei vs. 7530 lei per patient), the lethality rate (20.4% vs. 4.1%) being significant in the groups of patients with MRS and MSS. Conclusions. The socio-economic impact of patients with MRS infections is much higher than that of patients with MSS, which once again demonstrates the need to implement rational surveillance and control measures. |
||||||
Cuvinte-cheie risk factors, socio-economic impact, factori de risc, impact socio-economic |
||||||
|